Curt LaBelle is a highly experienced healthcare investor, operator, and Board member, with over 20 years of experience in the biotechnology, pharmaceuticals, diagnostics, and device sectors. He has an MBA and an MD from Columbia University, as well as a Bachelor's degree in Economics from Brigham Young University. LaBelle has led investments and served as a Board member for several successful companies, including Sirion Therapeutics, Eyenovia, moxidectin, KAI Pharmaceuticals, Impulse Monitoring, Exagen Diagnostics, Atomo, IanTech, and SafeOp Surgical, among others. He has also held operational roles in some portfolio companies. LaBelle is passionate about promoting the development of products that improve and save lives globally.